Shc and Enigma Are Both Required for Mitogenic Signaling by Ret/ptc2
Ret/ptc2 is a constitutively active, oncogenic form of the c-Ret receptor tyrosine kinase. Like the other papillary thyroid carcinoma forms of Ret, Ret/ptc2 is activated through fusion of the Ret tyrosine kinase domain to the dimerization domain of another protein. Investigation of requirements for...
Збережено в:
| Опубліковано в:: | Mol Cell Biol |
|---|---|
| Автори: | , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Taylor & Francis
1998
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC121481/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9528800/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/mcb.18.4.2298 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|